ReproCell Akcija

ReproCell Neto dug

Vrijednost Neto dug od ReproCell (4978.T) na dan 16. авг 2026. je -3,94 Млрд JPY. Prethodne godine, Neto dug je bio -6,57 Млрд JPY — promjena od -39,98% (viši).

Neto dug

-3,94 МлрдJPY

YoY

-39,98%

Zadnja ažuriranja:

Neto dug od ReproCell je 2026 -3,94 Млрд JPY. Neto dug od ReproCell je bio 2025 -6,57 Млрд JPY. Pad je time -39,98% viši u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

ReproCell Анализа акција

Šta radi ReproCell? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji ReproCell

Neto dug kompanije ReproCell iznosi -3,94 Млрд JPY u 2026. godini.

Neto dug od ReproCell se promijenio sa -6,57 Млрд JPY na -3,94 Млрд JPY, što predstavlja promjenu od -39,98%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj Neto dug ReproCell od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

Neto dug je ukupan dug minus gotovina i ekvivalenti gotovine. Pokazuje stvarno dužničko opterećenje nakon računanja dostupnih likvidnih sredstava.

Neto dug's JPY je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti Neto dug's ReproCell istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Билансни лист — ReproCell

Sve ključne metrike — ReproCell

Раст